INSP - Inspire Medical Systems, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $-0.33
|
Rev Est: $201.5M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$98.33
DETAILS
HIGH:
$180.00
LOW:
$60.00
MEDIAN:
$85.00
CONSENSUS:
$98.33
UPSIDE:
70.36%
Market Cap:
1.68B
Volume:
1,085,886
Avg Volume:
1,686,610
52 Week Range:
53.11-197.75
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.72
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
1,246
IPO Date:
2018-05-03
EPS (TTM):
4.95
P/E Ratio:
18.63
Revenue (TTM):
911.98M
Total Assets:
907.32M
Total Debt:
32.16M
Cash & Equiv:
104.81M
Rev Growth (5Y):
51.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
6.3%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-11 | $1.65 | $0.69 | +139.1% | $269.1M | $214.3M | +25.6% |
| 2025-11-03 | $0.38 | $-0.15 | +353.3% | $224.5M | $262.3M | -14.4% |
| 2025-08-04 | $0.45 | $0.22 | +104.5% | $217.1M | $214.5M | +1.2% |
| 2025-05-05 | $0.10 | $-0.23 | +143.5% | $201.3M | $227.7M | -11.6% |
| 2025-02-10 | $1.15 | $0.74 | +55.4% | $239.7M | $239.8M | 0.0% |
| 2024-11-04 | $0.60 | $0.08 | +650.0% | $203.2M | $197.6M | +2.8% |
| 2024-08-06 | $0.32 | $-0.14 | +328.6% | $195.9M | $189.5M | +3.4% |
| 2024-05-07 | $-0.34 | $-0.63 | +46.0% | $164.0M | $161.5M | +1.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 911.98M | 802.80M | 624.80M | 407.86M | 233.39M | 115.38M | 82.05M | 50.59M | 28.57M | 16.43M | 8.01M |
| Net Income | 145.42M | 53.51M | (21.15M) | (44.88M) | (42.04M) | (57.20M) | (33.24M) | (21.83M) | (17.51M) | (18.53M) | (21.34M) |
| EPS | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 | -1.50 | -1.30 | -1.49 | -1.71 |
| Total Assets | 907.32M | 808.38M | 676.81M | 564.88M | 295.08M | 281.19M | 181.25M | 200.08M | 25.09M | 13.12M | N/A |
| Total Debt | 32.16M | 31.79M | 24.85M | 8.87M | 34.09M | 30.63M | 25.35M | 24.93M | 16.46M | 15.69M | N/A |
| Cash & Equivalents | 104.81M | 150.15M | 185.54M | 441.59M | 214.47M | 190.52M | 22.86M | 97.29M | 8.96M | 6.68M | N/A |
| Operating Cash Flow | 116.98M | 130.25M | 24.65M | 11.57M | (20.12M) | (53.05M) | (32.85M) | (18.69M) | (15.79M) | (17.95M) | (22.25M) |
| Free Cash Flow | 78.48M | 91.12M | 1.02M | 2.47M | (24.79M) | (55.50M) | (35.59M) | (18.94M) | (16.20M) | (18.25M) | (22.60M) |
| FCF per Share | 2.67 | 3.06 | 0.03 | 0.09 | -0.91 | -2.13 | -1.49 | -1.30 | -1.20 | -1.46 | -1.81 |
| Book Value | 781.16M | 689.70M | 572.51M | 496.01M | 229.05M | 229.75M | 139.84M | 164.00M | 1.48M | (6.61M) | N/A |
| Cash & ST Investments | 308.27M | 445.55M | 460.38M | 451.41M | 214.47M | 234.36M | 149.47M | 188.21M | 16.14M | 6.68M | N/A |
| ROC Equity | 0.19 | 0.08 | -0.04 | -0.09 | -0.18 | -0.25 | -0.24 | -0.13 | -11.80 | N/A | N/A |